Literature DB >> 22572439

Recurrent and rapidly occurring pericardial tamponade in Erdheim Chester disease.

Oommen K George1, M S K Subhendu.   

Abstract

Erdheim Chester disease is a very rare histiocytic disorder characterised by tissue infiltration by lipid laden histiocytes. The most common presentation is bone pains typically involving the long bones. Over time almost 50% of the patients develop extraosseous involvement. The prognosis depends on the extent and distribution of the extraskeletal manifestations. Cardiovascular involvement is seen in up to 40% of the patients and the most common manifestations are periaortic fibrosis and pericardial involvement. Respiratory distress, extensive pulmonary fibrosis, and cardiac failure are the most common causes of death in these patients. Cardiac tamponade has also been documented to cause death in these patients. We describe a patient of Erdheim Chester disease who presented with recurrent and very rapidly occurring cardiac tamponade in a short duration of time and benefited from timely recognition and management.
Copyright © 2012 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22572439      PMCID: PMC3861001          DOI: 10.1016/S0019-4832(12)60023-6

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  8 in total

Review 1.  Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis.

Authors:  V Breuil; O Brocq; C Pellegrino; A Grimaud; L Euller-Ziegler
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

Review 2.  Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement.

Authors:  E Michel Azouz; Gaurav Saigal; Maria M Rodriguez; Antonello Podda
Journal:  Pediatr Radiol       Date:  2004-07-28

3.  [Erdheim-Chester disease and Langerhans histiocytosis. A fortuitous association?].

Authors:  A Simiele Narvarte; F Novoa Sanjurjo; N Gómez Rodríguez; I Antón Badiola
Journal:  An Med Interna       Date:  2004-12

Review 4.  Langerhans cell histiocytosis.

Authors:  K Windebank; V Nanduri
Journal:  Arch Dis Child       Date:  2009-05-19       Impact factor: 3.791

5.  Erdheim-Chester disease: a rare syndrome with a characteristic bone scintigraphy pattern.

Authors:  Trifon J Spyridonidis; Costas Giannakenas; Panagiota Barla; Dimitrios J Apostolopoulos
Journal:  Ann Nucl Med       Date:  2008-06-06       Impact factor: 2.668

Review 6.  Langerhans cell histiocytosis.

Authors:  R M Egeler; G J D'Angio
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

Review 7.  Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature.

Authors:  S-Y Sheu; R R Wenzel; C Kersting; R Merten; F Otterbach; K W Schmid
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

Review 8.  Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review.

Authors:  Julien Haroche; Zahir Amoura; Elisabeth Dion; Bertrand Wechsler; Nathalie Costedoat-Chalumeau; Patrice Cacoub; Richard Isnard; Thierry Généreau; Janine Wechsler; Nina Weber; Claire Graef; Philippe Cluzel; Philippe Grenier; Jean-Charles Piette
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

  8 in total
  3 in total

1.  Management of a patient with pericardial decompression syndrome and HOCM.

Authors:  Thierry Fozing; Nayef Zouri; Oliver Adam; Cem Oezbek
Journal:  BMJ Case Rep       Date:  2016-06-01

2.  Recurrent pericardial effusion and tamponade in a patient with Erdheim-Chester disease (ECD).

Authors:  Ajay Kumar Mishra; Sunithi Mani; Anu Anna George; Thambu David Sudarsanam
Journal:  BMJ Case Rep       Date:  2015-11-24

3.  Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease.

Authors:  Jaume Monmany; Esther Granell; Laura López; Pere Domingo
Journal:  BMJ Case Rep       Date:  2018-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.